{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T04:44:13Z","timestamp":1696394653877},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,29]],"date-time":"2011-10-29T00:00:00Z","timestamp":1319846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s11845-011-0775-4","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T17:03:13Z","timestamp":1319821393000},"page":"53-58","source":"Crossref","is-referenced-by-count":4,"title":["Rapid, early and sustained virological responses in a cohort of Irish patients treated with pegylated interferon and ribavirin for chronic hepatitis C virus infection"],"prefix":"10.1007","volume":"181","author":[{"given":"S.","family":"Sarwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. J.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"O\u2019Farrelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hegarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,29]]},"reference":[{"issue":"1","key":"775_CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Lauer","year":"2001","unstructured":"Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345(1):41\u201352","journal-title":"N Engl J Med"},{"issue":"3","key":"775_CR2","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.1002\/hep.510260704","volume":"26","author":"LB Seeff","year":"1997","unstructured":"Seeff LB (1997) Natural history of hepatitis C. Hepatology 26(3):21S\u201328S","journal-title":"Hepatology"},{"key":"775_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","volume":"55","author":"A Crax\u00ec","year":"2011","unstructured":"Crax\u00ec A, Flisiak R, Mondelli M, Peck-Radosavljevic M, Sarrazin C, Dusheiko G (2011) EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol 55:245\u2013264","journal-title":"J Hepatol"},{"issue":"1","key":"775_CR4","first-page":"35","volume":"23","author":"A Craxi","year":"2003","unstructured":"Craxi A, Licata A (2003) Clinical trial results of peginterferons in combination with ribavirin. Semin Liver Dis 23(1):35\u201346","journal-title":"Semin Liver Dis"},{"issue":"4","key":"775_CR5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49(4):1335\u20131374","journal-title":"Hepatology"},{"issue":"4","key":"775_CR6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.510270433","volume":"27","author":"S Zeuzem","year":"1998","unstructured":"Zeuzem S, Lee JH, Franke A et al (1998) Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa. Hepatology 27(4):1149\u20131156","journal-title":"Hepatology"},{"issue":"6","key":"775_CR7","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1440-1746.2007.04904.x","volume":"22","author":"JW Yu","year":"2007","unstructured":"Yu JW, Wang GQ, Sun LJ, Li XG, Li SC (2007) Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin. J Gastroenterol Hepatol 22(6):832\u2013836","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"775_CR8","first-page":"497","volume":"17","author":"MH Li","year":"2009","unstructured":"Li MH, Chen LJ, Qiu GH et al (2009) Prediction of sustained viral response to combinational therapy with interferon and ribavirin in chronic hepatitis C by rapid viral response. Zhonghua Gan Zang Bing Za Zhi 17(7):497\u2013500","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"3","key":"775_CR9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1053\/jhep.2003.50364","volume":"38","author":"GL Davis","year":"2003","unstructured":"Davis GL, Wong JB, McHutchison JG et al (2003) Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology 38(3):645\u2013652","journal-title":"Hepatology"},{"issue":"6","key":"775_CR10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22(6):696\u2013699","journal-title":"J Hepatol"},{"issue":"13","key":"775_CR11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR et al (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347(13):975\u2013982","journal-title":"N Engl J Med"},{"issue":"1","key":"775_CR12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2010.10.032","volume":"55","author":"MW Fried","year":"2011","unstructured":"Fried MW, Hadziyannis SJ, Shiffman ML, Messinger D, Zeuzem S (2011) Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection. J Hepatol 55(1):69\u201375","journal-title":"J Hepatol"},{"issue":"9286","key":"775_CR13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC et al (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358(9286):958\u2013965","journal-title":"Lancet"},{"issue":"4","key":"775_CR14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/135965350901400403","volume":"14","author":"M Martinot-Peignoux","year":"2009","unstructured":"Martinot-Peignoux M, Maylin S, Moucari R et al (2009) Virological response at 4\u00a0weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin. Antivir Ther 14(4):501\u2013511","journal-title":"Antivir Ther"},{"issue":"3","key":"775_CR15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2005.04.009","volume":"43","author":"P Ferenci","year":"2005","unstructured":"Ferenci P, Fried MW, Shiffman ML et al (2005) Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)\/ribavirin. J Hepatol 43(3):425\u2013433","journal-title":"J Hepatol"},{"issue":"7262","key":"775_CR16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge D, Fellay J, Thompson AJ et al (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461(7262):399\u2013401","journal-title":"Nature"}],"container-title":["Irish Journal of Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-011-0775-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-011-0775-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-011-0775-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T20:24:05Z","timestamp":1686428645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-011-0775-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,29]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1007\/s11845-011-0775-4","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,29]]}}}